Ftse Mib
34.191,79
-0,48%
DAX
19.210,81
-0,17%
S&P 500
5.870,62
-1,32%
NASDAQ
18.680,12
-2,24%
Bitcoin
91.585,13
0,58%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Trinity Biotech PLC (TRIB) Trinity Biotech PLC (TRIB) Notizie

Trinity Biotech PLC

TRIB
1,37
-0,11 (-7,43%)
16 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/11/202423:00EDGAR2Form F-3 - Registration statement by foreign private issuers
15/11/202419:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202415:00GLOBETrinity Biotech Announces Q3 2024 Financial Results
14/11/202423:26EDGAR2Form SC 13D/A - General Statement of Acquisition of..
07/11/202418:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202414:19GLOBETrinity Biotech Regains Compliance with Nasdaq Listing..
25/10/202419:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202419:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202414:45GLOBETrinity Biotech Announces Strategic Investment in Novus..
07/10/202416:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/10/202414:15GLOBETrinity Biotech Announces Positive Pre-Pivotal Trial Results..
02/10/202417:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/9/202421:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/9/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/9/202422:05GLOBETrinity Biotech Announces Acquisition of Metabolomics..
23/9/202414:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/9/202423:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/9/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/9/202422:05GLOBETrinity Biotech to Initiate CGM Market Study in India in..
10/9/202416:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/9/202422:05GLOBETrinity Biotech Provides an Update on the Continued..
05/9/202419:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202416:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/9/202417:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/9/202415:55GLOBETrinity Biotech Appoints Global Life Sciences Leader as..
29/8/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202423:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/8/202418:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/8/202422:05GLOBETrinity Biotech Announces Increased Orders for TrinScreen..
21/8/202422:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/8/202423:00GLOBETrinity Biotech Appoints Diabetes Care Veteran as Biosensor..
20/8/202419:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/8/202413:30GLOBETrinity Biotech Announces Q2 2024 Financial Results
13/8/202422:05GLOBETrinity Biotech to Announce Q2 2024 Financial Results
07/8/202423:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202423:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/8/202422:05GLOBETrinity Biotech Obtains an Extension to Demonstrate..
02/8/202415:24GLOBETrinity Biotech Provides Preliminary Second Quarter 2024..
12/7/202423:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202422:53EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/7/202422:07EDGAR2Form 20-F/A - Annual and transition report of foreign..
11/7/202412:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/7/202422:05GLOBETrinity Biotech Announces Appointment of A New CFO
24/6/202413:00GLOBETrinity Biotech to Begin European Pre-Pivotal Trial to..
10/6/202415:10GLOBETrinity Biotech Attending 84th Scientific Sessions of the..
03/6/202410:00GLOBETrinity Biotech Launches its Continuous Glucose Monitoring..
28/5/202413:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/5/202414:00GLOBETrinity Biotech Announces Q1 2024 Financial Results and..
16/5/202419:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/5/202415:18GLOBETrinity Biotech Announces Strategic Collaboration with..
Apertura: 1,34 Min: 1,34 Max: 1,53
Chiusura: 1,48

La tua Cronologia

NASDAQ
TRIB
Trinity Biotech
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network